ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)
Clinical trial NCT05894564 · COMPLETED
Trial details
- NCT number
- NCT05894564
- Sponsor
- Susanna Naggie, MD
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-25
- Primary completion
- 2023-02-27
- Enrollment
- 1208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.